AIGEN 2026 logo

AIGEN 2026

Program

Agenda for the two conference days, focused on AI, innovation, and genomics applied to public health.

The AIGEN 2026 agenda is organized across two complementary days. July 22 focuses on artificial intelligence, innovation, and adoption conditions in public health. July 23 centers on genomics, regional collaboration, and connections between research, hospitals, and the public system.

The schedule is designed to balance strategic content, technical exchange, and spaces for interaction among participants.

Full program

Agenda by day

Wednesday, July 22, 2026

AI and Innovation

A day focused on AI adoption, applied innovation, and collaboration opportunities for public health.

  1. 08:30
    Registration
  2. 09:00
    Welcome
  3. 09:30
    Keynote 1 | Steffen HĂ€rtel

    Cancer and Imaging: From Digital Transformation to AI-Driven Healthcare

  4. 10:30
    Coffee
  5. 11:00
    Talk 1 | Javier Quezada MarĂ­n

    Adaptive Pathology: A Patient-Centered Digital Paradigm

  6. 11:30
    Talk 2 | Gabriel NĂșñez-Vivanco

    Computational biology for health: from basic science to decision-making

  7. 12:00
    Panel: Innovation opportunities in health

    What does public health need to adopt AI? Participants: Carol Moraga, Renatto Anfossi, Steffen HĂ€rtel, and Alejandro Maass.

  8. 13:00-14:00
    Lunch
  9. 14:00
    Technology talks | Thermo Fisher (Susana Rasmussen)

    Massive Sequencing with Ion Torrent: Bringing Precision Oncology Closer to Patients

  10. 14:20
    Technology talks | Galénica (Juan Paulo Sagal)

    AI Solutions in Microscopy. From Routine to Research, Spatial Biology, Genomics, and Pathology

  11. 15:00
    Talk 3 | Gloria HenrĂ­quez

    Application of mathematical models and AI in digital health

  12. 15:30-16:30
    Flash talks
    • Giovanna Amaya Can Artificial Intelligence help us breathe better?
    • Santiago SepĂșlveda Chronic inflammation in the histogenetic pathways of gallbladder cancer and its convergence in the invasive tumor microenvironment: foundations for the development of chemopreventive and therapeutic strategies
    • Damariz GonzĂĄlez RFhap: software to separate the genome and improve resolution in genomic studies
    • Gabriel Cabas CRAB-MIL enables interpretable inference of whole-genome duplication from routine tumor histology
  13. 16:30-17:30
    Poster session and coffee

Thursday, July 23, 2026

Genomics

A day focused on genomics, regional platforms, and links between research and public health.

  1. 08:30
    Registration
  2. 09:00
    Welcome
  3. 09:30
    Keynote 1 | Lynnette Fernandez-Cuesta

    Exploring the biology of thoracic cancers through integrative multi-omics studies

  4. 10:30
    Coffee
  5. 11:00
    Talk 1 | Eduardo PĂ©rez-Palma

    CHANGER and severe epilepsies: Chilean genomics to improve genetic diagnoses and management of complex patients.

  6. 11:30
    Talk 2 | Tamara PĂ©rez Jeldres

    Bayesian network analysis reveals inflammation-dependent fungal interaction networks in ulcerative colitis from an underrepresented Latin American cohort

  7. 12:00
    Panel: Innovation opportunities in health

    What does public health need to move forward in genomic medicine? Participants: Tamara PĂ©rez, Mylene Cabrera, Alex Di Genova, and Eduardo PĂ©rez-Palma.

  8. 13:00-14:00
    Lunch
  9. 14:00
    Keynote 2 | Lilian Jara Sosa

    Genomic Epidemiology of Breast Cancer in Chile: From WES/WGS Analysis to the Creation of a Precision Population Panel

  10. 15:00
    Talk 3 | Valentina Parra Ortiz

    From pulmonary hypertension to cardiometabolic disease: contributions of systems biology to the study of estrogen-regulated metabolic networks

  11. 15:30-16:30
    Flash talks
    • Natalia Ibarra Transferability of polygenic scores for epilepsy in an admixed Chilean pediatric cohort (FONEPI)
    • David Weinstein Barriga Computational design of synthetic antibodies targeting early biomarkers of gallbladder cancer in Chile
    • MĂłnica RamĂ­rez Mapping pharmacogenomic opportunity in a Chilean public hospital: exposure burden, preventive panel architecture, and cost-opportunity in 23,728 outpatients
    • Alisson TerĂĄn From 3D bioimaging to automated cell analysis: classification of nuclei in liver tissue using 3DINOvit
  12. 16:30-16:50
    Technology talks | Oxford Nanopore Technologies

    Deciphering rare diseases and empowering clinical research

  13. 16:50-17:30
    Coffee and awards